Overall Technical outlook

Price Summary

On 2025-08-13, Ajanta Pharma Limited's stock opened at 2695.3, peaked at 2716.0, hit a low of 2653.9, and closed -0.88% lower at 2671.7, with 40260 shares changing hands.
For the 52-week period, the stock's highest price is 3426.5, and the lowest price is 2374.45.
Analysts expect the price of AJANTPHARM to vary between 2307.0 and 3293.0, with an average expected price near 3008.3333.

Technicals

Support and Resistance: The price of 2671.7 is supported at 2657.3 and encounters resistance at 2788.4. This suggests key levels where the price might find stability, with 2657.3 providing a base and 2788.4 acting as an upper boundary for AJANTPHARM.
AJANTPHARM supportResistance e256b5
Support/Resistance for AJANTPHARM


Aroon: The AROON is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
AJANTPHARM aroon e256b5
Aroon chart for Ajanta Pharma Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
AJANTPHARM bbands e256b5
Bolinger Bands chart for Ajanta Pharma Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a strong resistance level that could impede any upward trends. This resistance indicates that the market may struggle to break higher, reflecting ongoing bearish sentiment for AJANTPHARM.
AJANTPHARM psar e256b5
Parabolic Stop and Reverse chart for Ajanta Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
AJANTPHARM stoch e256b5
Stochastic chart for Ajanta Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral for AJANTPHARM, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
AJANTPHARM trippleSMA e256b5
Tripple SMA chart for Ajanta Pharma Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.